Progressive supranuclear palsy
Progressive supranuclear palsy (PSP; or the Steele-Richardson-Olszewski syndrome, after the doctors who described it in 1963) is a degenerative disease involving the deterioration and death of specific volumes of the brain.[1][2]Males and females are affected the same equally and there is no racial, geographical or occupational predilection. Approximately 6 people per 100,000 population have PSP. It has been described as a tauopathy.[3]
References
- ↑ Supranuclear ophthalmoplegia, pseudobulbar palsy, nuchal dystonia and dementia. A clinical report on eight cases of 'heterogeneous system degeneration'. Transactions of the American Neurological Association 88 (1963). p. 25–9.
- ↑ Progressive supranuclear palsy: a heterogeneous degeneration involving brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Archives of Neurology 10 (April 1964). p. 333–59. doi:10.1001/archneur.1964.00460160003001. Retrieved 2017-01-09.
- ↑ Rizzo G. Diffusion-weighted brain imaging study of patients with clinical diagnosis of corticobasal degeneration, progressive supranuclear palsy and Parkinson's disease. Brain 131 (Pt 10) (October 2008). p. 2690–700. doi:10.1093/brain/awn195.
